Ketoconazole treatment in Cushing's disease. Effect on the circadian profile of plasma ACTH and cortisol. 1988

M Terzolo, and M Panarelli, and A Piovesan, and M Torta, and P Paccotti, and A Angeli
Dipartimento di Biomedicina, Ospedale S. Luigi, Orbassano, Italy.

Ketoconazole is an inhibitor of adrenal steroidogenesis used in the treatment of Cushing's disease. Previous data obtained with single blood sampling were controversial as to increased ACTH levels compensatory to the cortisol fall. We have evaluated by chronobiological procedures the circadian profiles of plasma ACTH and cortisol in three patients with Cushing's disease before and after a six-month course of therapy with ketoconazole (600 mg daily). None of the patients complained of any adverse subjective reaction; in particular no sign or symptom of hypoadrenalism and/or hepatotoxicity was recorded. Ketoconazole treatment markedly improved the clinical setting and caused a highly significant (p less than 0.0001) reduction of mean 24-h cortisol values (ciradian MESOR). The expected rise of ACTH did not take place; rather, we detected a slight decrease of the mean circadian MESOR (p less than 0.05). Our data, althought obtained in a very small number of patients, suggest that ketoconazole may have an additional action at central level, at least in some cases of Cushing's disease.

UI MeSH Term Description Entries
D007654 Ketoconazole Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. Nizoral,R-41400,R41,400,R41400,R 41400
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Terzolo, and M Panarelli, and A Piovesan, and M Torta, and P Paccotti, and A Angeli
January 1987, Hormone and metabolic research. Supplement series,
M Terzolo, and M Panarelli, and A Piovesan, and M Torta, and P Paccotti, and A Angeli
November 1977, Bollettino della Societa italiana di biologia sperimentale,
M Terzolo, and M Panarelli, and A Piovesan, and M Torta, and P Paccotti, and A Angeli
November 1976, Bollettino della Societa italiana di biologia sperimentale,
M Terzolo, and M Panarelli, and A Piovesan, and M Torta, and P Paccotti, and A Angeli
January 1988, Endokrynologia Polska,
M Terzolo, and M Panarelli, and A Piovesan, and M Torta, and P Paccotti, and A Angeli
January 1982, Clinical and experimental hypertension. Part A, Theory and practice,
M Terzolo, and M Panarelli, and A Piovesan, and M Torta, and P Paccotti, and A Angeli
January 1991, Clinical endocrinology,
M Terzolo, and M Panarelli, and A Piovesan, and M Torta, and P Paccotti, and A Angeli
October 2007, Arquivos brasileiros de endocrinologia e metabologia,
M Terzolo, and M Panarelli, and A Piovesan, and M Torta, and P Paccotti, and A Angeli
March 2013, Endocrine connections,
M Terzolo, and M Panarelli, and A Piovesan, and M Torta, and P Paccotti, and A Angeli
May 1979, The Journal of clinical endocrinology and metabolism,
M Terzolo, and M Panarelli, and A Piovesan, and M Torta, and P Paccotti, and A Angeli
July 1990, The Journal of the Association of Physicians of India,
Copied contents to your clipboard!